DAMORA THERAPEUTICS, INC. Operating Lease, Payments
DAMORA THERAPEUTICS, INC. (DMRA) reported Operating Lease, Payments of $20.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-19.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-03-19
- DAMORA THERAPEUTICS, INC. operating lease, payments for the quarter ending 2025-12-31 was $5.00K, a 84.85% decline year-over-year.
- DAMORA THERAPEUTICS, INC. operating lease, payments for the quarter ending 2025-09-30 was $5.00K, a 90.00% decline year-over-year.
- DAMORA THERAPEUTICS, INC. operating lease, payments for the quarter ending 2025-06-30 was $5.00K, a 89.58% decline year-over-year.
- DAMORA THERAPEUTICS, INC. operating lease, payments for the quarter ending 2025-03-31 was $5.00K, a 94.57% decline year-over-year.
- DAMORA THERAPEUTICS, INC. operating lease, payments for fiscal 2025 was $20.00K, a 91.03% decline from fiscal 2024.
- DAMORA THERAPEUTICS, INC. operating lease, payments for fiscal 2024 was $223.00K, a 60.53% decline from fiscal 2023.
- DAMORA THERAPEUTICS, INC. operating lease, payments for fiscal 2023 was $565.00K, a 8.03% increase from fiscal 2022.
- DAMORA THERAPEUTICS, INC. operating lease, payments for fiscal 2022 was $523.00K, a 1.95% increase from fiscal 2021.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2025-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $10.00K derived: sum of 2 quarters · filed 2026-03-19 | $15.00K derived: sum of 3 quarters · filed 2026-03-19 | $20.00K 10-K · filed 2026-03-19 |
| 2025-09-30 | $5.00K 10-Q · filed 2025-11-06 | $10.00K derived: sum of 2 quarters · filed 2025-11-06 | $15.00K 10-Q · filed 2025-11-06 | $48.00K derived: sum of 4 quarters · filed 2026-03-19 |
| 2025-06-30 | $5.00K 10-Q · filed 2025-08-05 | $10.00K 10-Q · filed 2025-08-05 | $43.00K derived: sum of 3 quarters · filed 2026-03-19 | $93.00K derived: sum of 4 quarters · filed 2026-03-19 |
| 2025-03-31 | $5.00K 10-Q · filed 2025-05-08 | $38.00K derived: sum of 2 quarters · filed 2026-03-19 | $88.00K derived: sum of 3 quarters · filed 2026-03-19 | $136.00K derived: sum of 4 quarters · filed 2026-03-19 |
| 2024-12-31 | $33.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $83.00K derived: sum of 2 quarters · filed 2026-03-19 | $131.00K derived: sum of 3 quarters · filed 2026-03-19 | $223.00K 10-K · filed 2026-03-19 |
| 2024-09-30 | $50.00K 10-Q · filed 2025-11-06 | $98.00K derived: sum of 2 quarters · filed 2025-11-06 | $190.00K 10-Q · filed 2025-11-06 | $361.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $48.00K 10-Q · filed 2025-08-05 | $140.00K 10-Q · filed 2025-08-05 | $311.00K derived: sum of 3 quarters · filed 2025-08-05 | $432.00K derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | $92.00K 10-Q · filed 2025-05-08 | $263.00K derived: sum of 2 quarters · filed 2025-05-08 | $384.00K derived: sum of 3 quarters · filed 2025-05-08 | $509.00K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $171.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19 | $292.00K derived: sum of 2 quarters · filed 2025-03-19 | $417.00K derived: sum of 3 quarters · filed 2025-03-19 | $565.00K 10-K · filed 2025-03-19 |
| 2023-09-30 | $121.00K 10-Q · filed 2024-11-01 | $246.00K derived: sum of 2 quarters · filed 2024-11-01 | $394.00K 10-Q · filed 2024-11-01 | $549.00K derived: sum of 4 quarters · filed 2024-11-01 |
| 2023-06-30 | $125.00K 10-Q · filed 2024-08-12 | $273.00K 10-Q · filed 2024-08-12 | $428.00K derived: sum of 3 quarters · filed 2024-08-12 | $562.00K derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $148.00K 10-Q · filed 2024-04-29 | $303.00K derived: sum of 2 quarters · filed 2024-04-29 | $437.00K derived: sum of 3 quarters · filed 2024-04-29 | $557.00K derived: sum of 4 quarters · filed 2024-04-29 |
| 2022-12-31 | $155.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $289.00K derived: sum of 2 quarters · filed 2024-03-08 | $409.00K derived: sum of 3 quarters · filed 2024-03-08 | $523.00K 10-K · filed 2024-03-08 |
| 2022-09-30 | $134.00K 10-Q · filed 2023-11-06 | $254.00K derived: sum of 2 quarters · filed 2023-11-06 | $368.00K 10-Q · filed 2023-11-06 | $478.00K derived: sum of 4 quarters · filed 2023-11-06 |
| 2022-06-30 | $120.00K 10-Q · filed 2023-07-31 | $234.00K 10-Q · filed 2023-07-31 | $344.00K derived: sum of 3 quarters · filed 2023-07-31 | $486.00K derived: sum of 4 quarters · filed 2023-07-31 |
| 2022-03-31 | $114.00K 10-Q · filed 2023-04-28 | $224.00K derived: sum of 2 quarters · filed 2023-04-28 | $366.00K derived: sum of 3 quarters · filed 2023-04-28 | $508.00K derived: sum of 4 quarters · filed 2023-04-28 |
| 2021-12-31 | $110.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $252.00K derived: sum of 2 quarters · filed 2023-03-09 | $394.00K derived: sum of 3 quarters · filed 2023-03-09 | $513.00K 10-K · filed 2023-03-09 |
| 2021-09-30 | $142.00K 10-Q · filed 2022-11-08 | $284.00K derived: sum of 2 quarters · filed 2022-11-08 | $403.00K 10-Q · filed 2022-11-08 | $480.00K derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $142.00K 10-Q · filed 2022-07-29 | $261.00K 10-Q · filed 2022-07-29 | $338.00K derived: sum of 3 quarters · filed 2022-07-29 | $405.00K derived: sum of 4 quarters · filed 2022-07-29 |
| 2021-03-31 | $119.00K 10-Q · filed 2022-04-29 | $196.00K derived: sum of 2 quarters · filed 2022-04-29 | $263.00K derived: sum of 3 quarters · filed 2022-04-29 | $301.00K derived: sum of 4 quarters · filed 2022-04-29 |
| 2020-12-31 | $77.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17 | $144.00K derived: sum of 2 quarters · filed 2022-02-17 | $182.00K derived: sum of 3 quarters · filed 2022-02-17 | $213.00K 10-K · filed 2022-02-17 |
| 2020-09-30 | $67.00K 10-Q · filed 2021-11-04 | $105.00K derived: sum of 2 quarters · filed 2021-11-04 | $136.00K 10-Q · filed 2021-11-04 | $173.00K derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $38.00K 10-Q · filed 2021-08-05 | $69.00K 10-Q · filed 2021-08-05 | $106.00K derived: sum of 3 quarters · filed 2021-08-05 | $135.00K derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $31.00K 10-Q · filed 2021-05-04 | $68.00K derived: sum of 2 quarters · filed 2021-05-04 | $97.00K derived: sum of 3 quarters · filed 2021-05-04 | |
| 2019-12-31 | $37.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $66.00K derived: sum of 2 quarters · filed 2021-03-29 | $129.00K 10-K · filed 2021-03-29 | |
| 2019-09-30 | $29.00K 10-Q · filed 2020-12-11 | $92.00K 10-Q · filed 2020-12-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |